Here, we report that BMS599626 inhibits the efflux activity of ABCG2 at nontoxic, low nanomolar concentrations, thereby increasing the chemosensitivity of cancer cells to their substrate chemotherapeutic agents. Here, ABCG2 is linked to cancer.